Jul 15, 2026
For most of medical history, treating disease meant casting a wide net. Chemotherapy attacked every fast-dividing cell it could find, healthy or cancerous. Broad-spectrum drugs treated symptoms without ever asking why a particular patient's biology behaved the way it did. That era is ending. Targeted therapeutics, ...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper